南美洲分子生物学酶、试剂盒和试剂市场预测至 2028 年 - COVID-19 影响和按产品(酶、试剂盒和试剂)、应用(表观遗传学、测序、合成生物学、聚合酶链反应等)进行的区域分析,以及最终用户(生物技术和制药公司、医院和诊断中心、学术和研究机构)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 163    |    Report Code: TIPRE00025777    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South America Molecular Biology Enzymes, Kits, and Reagents Market

市场介绍

SAM分子生物酶、试剂盒及试剂市场以巴西、阿根廷等两大国家为基础进行研究并以 SAM 的其余部分为基础。最近的技术发展对巴西经济产生了直接影响,巴西经济在很大程度上取得了进步。生物技术领域的进步和更高的发展速度以及该地区本地参与者的发展可能会推动分子生物酶、试剂盒和试剂盒的市场。试剂。该地区的分子生物酶、试剂盒和试剂市场可能会快速增长,预计在预测期内将增加其在全球市场中的市场份额。

SAM 的市场份额不断增长自爆发以来的 COVID-19 病例数。巴西、阿根廷和哥伦比亚的病例正在增加。 COVID-19预计将导致该地区最严重的经济衰退,导致2020年地区GDP萎缩9.1%。这预计将使贫困人口增加4500万,极端贫困人口增加2800万。发病率的增加支持了市场的增长。制药及生物技术投资于新分子实体的研发。大流行对研发过程没有影响,因为大流行的研发活动增加,以寻找更好的药物来治愈危及生命的疾病。这些因素对 SAM 分子生物学酶、试剂盒和试剂盒有很大影响。试剂市场。     

 

            

市场概况和动态

SAM 的分子生物学酶、试剂盒和试剂市场预计将从美国增长2021年为4.0979亿美元,到2028年为11.6737亿美元;预计 2021 年至 2028 年复合年增长率为 16.1%。对分子生物学酶、试剂盒和试剂市场增长做出贡献的一些主要国家包括哥伦比亚、秘鲁和玻利维亚。分子生物学酶、试剂盒和试剂的市场增长归因于传染病的增加、分子诊断意识的提高以及先进医疗设施和生物制药行业的采用。非传染性疾病 (NCD) 是一种长期、进展缓慢的疾病,可能会给受影响的人带来严重的并发症。非传染性疾病占全球每年死亡人数的 63%,其中包括癌症、糖尿病和心血管疾病等疾病,并影响中低收入国家。

此外,诊断公司的扩张活动正在推动还创造了对酶、试剂盒和试剂的需求。其他因素包括生命科学和药物发现研究机构数量不断增加,研发活动数量不断增加,以及政府推动国内生物技术机构研究的举措不断增加。这导致对各种分子生物学酶和试剂的巨大需求,这将进一步促进该国该市场的增长。

主要细分市场

SAM 分子生物学酶、试剂盒和试剂市场分为产品、应用程序、最终用户和国家/地区。根据产品,分子生物学酶、试剂盒和试剂市场分为酶和试剂盒和试剂。试剂。按酶,市场进一步细分为聚合酶、连接酶、逆转录酶、磷酸酶、蛋白酶和蛋白酶、限制性内切酶等。套件和2020年,试剂细分市场占有较大市场份额。分子生物学酶、试剂盒和试剂市场根据应用细分为表观遗传学、测序、合成生物学、聚合酶链反应等。 2020年,测序领域占据最大的市场份额。就最终用户而言,分子生物学酶、试剂盒和试剂市场分为生物技术和制药公司、医院和诊断中心以及学术和研究机构。 2020 年,生物技术和制药公司细分市场占据最大份额。按国家/地区划分,SAM 分子生物学酶、试剂盒和试剂市场分为巴西、阿根廷和 SAM 的其他地区。巴西在 2020 年占据最大的市场份额。

主要来源和上市公司

一些主要的一手和二手来源提到用于准备 SAM 分子生物学酶、试剂盒和试剂市场报告的资料包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有安捷伦科技公司(Agilent Technologies, Inc.); F. 霍夫曼拉罗什有限公司;照明公司;默克集团;子午线生物科学公司;普洛麦格公司;凯杰;和 THERMO FISHER SCIENTIFIC INC.         

购买报告的理由< /u>

  • 了解 SAM 分子生物学酶、试剂盒和试剂的市场格局,并确定最有可能保证丰厚回报的细分市场。< /li>
  • 了解 SAM 分子生物学酶、试剂盒和试剂市场不断变化的竞争格局,保持领先地位。
  • 有效规划 SAM 分子生物学领域的并购和合作交易通过识别最有希望销售的细分市场,了解酶、试剂盒和试剂市场。
  • 通过对 SAM 分子生物学酶、试剂盒、和试剂市场。
  • 获取 SAM 地区 2021-2028 年各个细分市场的市场收入预测

SAM

分子生物学酶、试剂盒和试剂市场

细分

SAM

分子

生物酶、试剂盒和试剂

市场 -

副产品

    • 聚合酶
    • 连接酶
    • 反转录酶
    • 磷酸酶
    • 蛋白酶和蛋白酶
    • 限制性内切酶
    • 其他
  • 其他
li>
  • 试剂盒和试剂
  • SAM 分子生物学酶、试剂盒和试剂市场 - 作者:

    应用

    • 表观遗传学
    • 测序
    • 合成生物学
    • 聚合酶链反应
    • li>
    • 其他

    SAM 分子生物学酶、试剂盒和试剂市场 - 按最终用户划分

    < ul>
  • 生物技术和制药公司
  • 医院和诊断中心
  • 学术和研究机构
  • SAM 分子生物酶、试剂盒和试剂市场 - 按国家/地区

    • 巴西
    • 阿根廷  
    • SAM 的其他地区

    SAM 分子生物学酶、试剂盒和试剂市场 - 公司简介

    • 安捷伦科技公司
    • F. HOFFMANN-LA ROCHE LTD
    • Illumina, Inc.
    • Merck KGAA
    • MERIDIAN BIOSCIENCE, INC
    • Promega Corporation
    • < li>Qiagen
    • 赛默飞世尔科技有限公司
     

    South America Molecular Biology Enzymes, Kits, and Reagents Strategic Insights

    Strategic insights for South America Molecular Biology Enzymes, Kits, and Reagents involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/south-america-molecular-biology-enzymes-kits-and-reagents-market-strategic-framework.webp
    Get more information on this report

    South America Molecular Biology Enzymes, Kits, and Reagents Report Scope

    Report Attribute Details
    Market size in 2021 US$ 409.79 Million
    Market Size by 2028 US$ 1,167.37 Million
    Global CAGR (2021 - 2028) 16.1%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 产品
    • 酶
    • 试剂盒和试剂
    By 应用
    • 表观遗传学
    • 测序
    • 合成生物学
    • 聚合酶链反应
    By 最终用户
    • 生物技术和制药公司
    • 医院和诊断中心
    • 学术和研究机构
    Regions and Countries Covered 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区
    Market leaders and key company profiles
  • Agilent Technologies, Inc.
  • F. HOFFMANN-LA ROCHE LTD
  • Illumina, Inc.
  • Merck KGAA
  • MERIDIAN BIOSCIENCE, INC
  • Promega Corporation
  • Qiagen
  • THERMO FISHER SCIENTIFIC INC
  • Get more information on this report

    South America Molecular Biology Enzymes, Kits, and Reagents Regional Insights

    The regional scope of South America Molecular Biology Enzymes, Kits, and Reagents refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-america-molecular-biology-enzymes-kits-and-reagents-market-geography.webp
    Get more information on this report

    The List of Companies - South America Molecular Biology Enzymes, Kits, and Reagents Market

    1. Agilent Technologies, Inc.
    2. F. HOFFMANN-LA ROCHE LTD
    3. Illumina, Inc.
    4. Merck KGAA
    5. MERIDIAN BIOSCIENCE, INC
    6. Promega Corporation
    7. Qiagen
    8. THERMO FISHER SCIENTIFIC INC
    Frequently Asked Questions
    How big is the South America Molecular Biology Enzymes, Kits, and Reagents Market?

    The South America Molecular Biology Enzymes, Kits, and Reagents Market is valued at US$ 409.79 Million in 2021, it is projected to reach US$ 1,167.37 Million by 2028.

    What is the CAGR for South America Molecular Biology Enzymes, Kits, and Reagents Market by (2021 - 2028)?

    As per our report South America Molecular Biology Enzymes, Kits, and Reagents Market, the market size is valued at US$ 409.79 Million in 2021, projecting it to reach US$ 1,167.37 Million by 2028. This translates to a CAGR of approximately 16.1% during the forecast period.

    What segments are covered in this report?

    The South America Molecular Biology Enzymes, Kits, and Reagents Market report typically cover these key segments-

  • 产品 (酶, 试剂盒和试剂)
  • 应用 (表观遗传学, 测序, 合成生物学, 聚合酶链反应)
  • 最终用户 (生物技术和制药公司, 医院和诊断中心, 学术和研究机构)
  • What is the historic period, base year, and forecast period taken for South America Molecular Biology Enzymes, Kits, and Reagents Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Molecular Biology Enzymes, Kits, and Reagents Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South America Molecular Biology Enzymes, Kits, and Reagents Market?

    The South America Molecular Biology Enzymes, Kits, and Reagents Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Agilent Technologies, Inc.
  • F. HOFFMANN-LA ROCHE LTD
  • Illumina, Inc.
  • Merck KGAA
  • MERIDIAN BIOSCIENCE, INC
  • Promega Corporation
  • Qiagen
  • THERMO FISHER SCIENTIFIC INC
  • Who should buy this report?

    The South America Molecular Biology Enzymes, Kits, and Reagents Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Molecular Biology Enzymes, Kits, and Reagents Market value chain can benefit from the information contained in a comprehensive market report.